This is a demo store. No orders will be fulfilled.

Namilumab (anti-GM-CSF) - Primary antibody, specific to CSF2, Human IgG1, INHIBITOR of Granulocyte-macrophage colony-stimulating factor inhibitor, INHIBITOR of Granulocyte-macrophage colony-stimulating factor inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Cynomolgus monkey,Human,Rhesus monkey
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab175608
Grouped product items
SKU Size
Availability
Price Qty
Ab175608-100μg
100μg
10
$109.90
Ab175608-1mg
1mg
4
$519.90
Ab175608-5mg
5mg
1
$1,399.90
Ab175608-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,239.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Namilumab (anti-GM-CSF) - Primary antibody, specific to CSF2, Human IgG1, INHIBITOR of Granulocyte-macrophage colony-stimulating factor inhibitor
Synonyms Colony stimulating factor 2 (granulocyte-macrophage) antibody | Colony Stimulating Factor 2 antibody | Colony stimulating factor antibody | Colony-stimulating factor antibody | CSF 2 antibody | CSF antibody | CSF2 antibody | CSF2_HUMAN antibody | GM-CSF a
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity CSF2
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Granulocyte-macrophage colony-stimulating factor inhibitor
Product Description

Namilumab (anti-GM-CSF) is a human immunoglobulin G1 (IgG1) monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 26.3 kDa (Light Chain) & 51.1 kDa (Heavy Chain), under reducing conditions; 190.1 kDa, under non-reducing conditions.
Purification Method Protein A purified
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS 1206681-39-1

Associated Targets(Human)

CSF2 Tbio Granulocyte-macrophage colony-stimulating factor (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Namilumab (anti-GM-CSF) (Ab175608) - ELISA
Immobilized Recombinant Human GM-CSF Protein (rp156011) at 1.0 μg/mL can bind Namilumab (anti-GM-CSF) (Ab175608) with the EC50 of 62.67 ng/mL.

Namilumab (anti-GM-CSF) (Ab175608) - SEC
The purity of Namilumab (anti-GM-CSF) (Ab175608) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0607166 Certificate of Analysis Jun 21, 2024 Ab175608
ZJ24F0607165 Certificate of Analysis Jun 21, 2024 Ab175608
ZJ24F0607164 Certificate of Analysis Jun 21, 2024 Ab175608

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.